ADC Therapeutics Directors Grant 45K RSUs, Sell 12.6K Shares – A Tale of Confidence Amid Bearish Market .
Insider RSU grants and tax‑sales at ADC Therapeutics reveal board confidence in the antibody‑drug pipeline, while steady holdings signal no market panic.
4 minutes to read

